Skip to main content

Table 2 Weighted mean region-specific HBsAg prevalence in blood donors and hospital settings

From: Age- and region-specific hepatitis B prevalence in Turkey estimated using generalized linear mixed models: a systematic review

Study group

    

%HBsAg prevalence (range)

  

Category

no.studies

N

n

Region*

Weighted mean all data

Weighted mean published data

Pvalue

References

Blood donors

13

658662

16788

A

2.53 (1.10, 8.70)

2.33 (1.70, 2.75)

0.51

[3440] (i-n)

 

16

223949

6389

B

2.68 (1.70, 4.22)

3.44 (2.60, 4.20)

0.14

[4146] (o-x)

 

4

149918

6675

C

4.25 (1.70, 4.90)

4.45 (2.92, 4.90)

0.50

[4749] (y)

Hospital†

5

37497

2977

A

3.40 (1.30, 13.80)

1.30 (0.90, 1.63)

0.40

[50] (z-cc)

 

6

100343

7781

B

7.15 (2.90, 13.60)

5.73 (2.90, 13.60)

1.00

[51, 52] (dd-gg)

 

2

28392

6037

C

-

10.88 (9.60, 21.30)

-

[53, 54]

  1. Abbreviations: N number of subjects, n number of cases
  2. P value calculated by the two-sided Mann-Whitney test (difference in prevalence of all data and only published data)
  3. * Region A: Marmara and Aegean, B: Black Sea, Central Anatolia and Mediterranean, C: Eastern and South-eastern
  4. † Studies based in hospital settings on non-liver-related conditions